Boța, M.; Vlaia, L.; Jîjie, A.-R.; Marcovici, I.; Crişan, F.; Oancea, C.; Dehelean, C.A.; Mateescu, T.; Moacă, E.-A.
Exploring Synergistic Interactions between Natural Compounds and Conventional Chemotherapeutic Drugs in Preclinical Models of Lung Cancer. Pharmaceuticals 2024, 17, 598.
https://doi.org/10.3390/ph17050598
AMA Style
Boța M, Vlaia L, Jîjie A-R, Marcovici I, Crişan F, Oancea C, Dehelean CA, Mateescu T, Moacă E-A.
Exploring Synergistic Interactions between Natural Compounds and Conventional Chemotherapeutic Drugs in Preclinical Models of Lung Cancer. Pharmaceuticals. 2024; 17(5):598.
https://doi.org/10.3390/ph17050598
Chicago/Turabian Style
Boța, Mihaela, Lavinia Vlaia, Alex-Robert Jîjie, Iasmina Marcovici, Flavia Crişan, Cristian Oancea, Cristina Adriana Dehelean, Tudor Mateescu, and Elena-Alina Moacă.
2024. "Exploring Synergistic Interactions between Natural Compounds and Conventional Chemotherapeutic Drugs in Preclinical Models of Lung Cancer" Pharmaceuticals 17, no. 5: 598.
https://doi.org/10.3390/ph17050598
APA Style
Boța, M., Vlaia, L., Jîjie, A.-R., Marcovici, I., Crişan, F., Oancea, C., Dehelean, C. A., Mateescu, T., & Moacă, E.-A.
(2024). Exploring Synergistic Interactions between Natural Compounds and Conventional Chemotherapeutic Drugs in Preclinical Models of Lung Cancer. Pharmaceuticals, 17(5), 598.
https://doi.org/10.3390/ph17050598
